Opus Genetics, Inc. (IRD)

NASDAQ

$4.06

$+0.08

(+1.87%)

Regular Market

Opus Genetics, Inc. (IRD) Live Price Chart

Last updated: ⁦2026-10-21 16:15:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Opus Genetics, Inc. (IRD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.06, with a market capitalization of $317.81M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.70 to $7.07. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$317.81M
Open	$4.03
Day's High	$7.07
Day's Low	$0.65
Previous Close	$4.01
Volume	346.57K
Average Volume	2.51M
P/E Ratio	--
52-Week High	$7.07
52-Week Low	$1.70
Dividend Yield	--
Earnings Date	--

Opus Genetics, Inc. (IRD) Stock Price Today

Opus Genetics, Inc. (IRD) is currently trading at $4.06 as of 2026-10-21 16:13:00, up 1.12% ($0.04) from the previous close of $4.01

During today's regular trading session, IRD has traded between $0.65 and $7.07, with a trading volume of 346.57K shares. The current price is near the middle of today's range.

Opus Genetics, Inc. (IRD) 7-Day Stock Price Change

Over the past seven days, Opus Genetics, Inc. (IRD) moved from $4.64 to $4.06, representing a decline of 12.61% ($0.59).

The stock traded between $3.69 and $4.88 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.80 million shares, down versus the previous seven-day period, indicating lower trading activity.

IRD 52-Week Price Position

Position in Range: 43.9%

52W Low$1.70

52W High$7.07

IRD is currently trading at $4.06, placing it 43.9% of the way from its 52-week low of $1.70 to its 52-week high of $7.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Opus Genetics, Inc. (IRD)?

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.

Opus Genetics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	28
Exchange	NASDAQ
Company Website	https://www.opusgtx.com

How to Buy Opus Genetics, Inc. (IRD) Stock on MEXC

Eligible investors can buy real shares of Opus Genetics, Inc. (IRD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IRD and Place Your Order

Open the RealStocks trading page and search for IRD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Opus Genetics, Inc. (IRD) stock price today?

Opus Genetics, Inc. (IRD) is currently trading at $ 4.06, up 1.12% ($0.04) from the previous close of $ 4.01. Intraday prices update in real time during regular trading hours.

2.Is IRD stock going up or down today?

As of 2026-10-21 16:13:00, IRD is trading at $ 4.06, up 1.12% ($0.04) from its previous close of $ 4.01. The stock has traded between $ 0.65 and $ 7.07 during today’s regular session. Past price movements do not guarantee future results.

3.What is IRD pre-market price?

As of 2026-10-21 16:13:00, IRD is trading at $ 3.99 in pre-market trading, down 0.50% ($0.02) from the previous close of $ 4.01. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IRD after-hours price?

As of 2026-10-21 16:13:00, IRD is trading at $ 4.07 in after-hours trading, up 1.47% ($0.06) from the regular-session close of $ 4.01. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IRD stock trading now?

IRD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IRD sit relative to its 52-week high and low?

Over the past 52 weeks, IRD has traded between a low of $ 1.70 and a high of $ 7.07. At $ 4.06, the stock is positioned 43.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Opus Genetics, Inc. in?

Opus Genetics, Inc. (IRD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Opus Genetics, Inc.'s market capitalization and where is it listed?

Opus Genetics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 317.81M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IRD valued in terms of P/E ratio and EPS?

IRD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.29. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Opus Genetics, Inc. pay a dividend?

Opus Genetics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.